BAM
PGEN icon

Belpointe Asset Management’s Precigen PGEN Stock Holding History

Belpointe Asset Management’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-445
Closed -$472 – 2550
2023
Q1 		$472 Hold
445
– – ﹤0.01% 3599
2022
Q4 		$677 Buy
+445
New +$765 ﹤0.01% 3505

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Belpointe Asset Management's PGEN Position: Q2 2023 in Review

Belpointe Asset Management sold out of Precigen (PGEN) in Q2 2023, closing a stake of 445 shares — an estimated $472 sold.

Belpointe Asset Management first reported a position in PGEN in Q4 2022 and held it in 2 quarters. The position peaked at $677 in Q4 2022. 138 funds tracked by Wall St. Rank hold PGEN as of Q2 2023.

  • Belpointe Asset Management reported no remaining Precigen position as of Q2 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 445 Precigen shares in Q2 2023, an estimated $472.
  • Belpointe Asset Management first reported a position in Precigen in Q4 2022 and held it in 2 quarters.
  • Belpointe Asset Management's Precigen position peaked at $677 in Q4 2022.
  • 138 funds tracked by Wall St. Rank held Precigen as of Q2 2023.

Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.